Nisa Investment Advisors LLC Increases Stock Position in Aflac Incorporated (NYSE:AFL)

Nisa Investment Advisors LLC raised its position in shares of Aflac Incorporated (NYSE:AFL - Free Report) by 2.0% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 245,758 shares of the financial services provider's stock after purchasing an additional 4,901 shares during the period. Nisa Investment Advisors LLC's holdings in Aflac were worth $27,476,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also bought and sold shares of the company. Y.D. More Investments Ltd bought a new position in shares of Aflac during the 2nd quarter worth $25,000. Dixon Mitchell Investment Counsel Inc. bought a new position in Aflac during the first quarter worth about $34,000. Cedar Wealth Management LLC purchased a new position in shares of Aflac in the first quarter worth about $50,000. Fairscale Capital LLC bought a new stake in shares of Aflac in the second quarter valued at approximately $54,000. Finally, HHM Wealth Advisors LLC lifted its stake in shares of Aflac by 178.6% during the 2nd quarter. HHM Wealth Advisors LLC now owns 624 shares of the financial services provider's stock valued at $56,000 after buying an additional 400 shares in the last quarter. 67.44% of the stock is owned by institutional investors.

Aflac Price Performance

NYSE:AFL traded up $0.21 during midday trading on Tuesday, hitting $110.00. The company had a trading volume of 2,846,611 shares, compared to its average volume of 2,222,271. The stock's fifty day moving average price is $110.41 and its 200-day moving average price is $97.16. Aflac Incorporated has a 52-week low of $75.07 and a 52-week high of $115.50. The company has a quick ratio of 0.10, a current ratio of 0.10 and a debt-to-equity ratio of 0.29. The company has a market capitalization of $62.50 billion, a PE ratio of 12.14, a P/E/G ratio of 2.62 and a beta of 0.95.

Aflac (NYSE:AFL - Get Free Report) last announced its quarterly earnings data on Wednesday, July 31st. The financial services provider reported $1.83 EPS for the quarter, beating the consensus estimate of $1.60 by $0.23. The firm had revenue of $5.14 billion for the quarter, compared to analyst estimates of $4.10 billion. Aflac had a return on equity of 16.22% and a net margin of 28.35%. The company's revenue was down .7% on a year-over-year basis. During the same period in the prior year, the company earned $1.58 EPS. As a group, research analysts expect that Aflac Incorporated will post 6.76 earnings per share for the current year.

Aflac Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, September 2nd. Stockholders of record on Wednesday, August 21st were paid a $0.50 dividend. The ex-dividend date of this dividend was Wednesday, August 21st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.82%. Aflac's dividend payout ratio (DPR) is 22.08%.

Insider Activity at Aflac

In other Aflac news, Director Thomas J. Kenny sold 2,000 shares of the business's stock in a transaction on Wednesday, August 7th. The shares were sold at an average price of $98.94, for a total value of $197,880.00. Following the completion of the sale, the director now directly owns 18,158 shares of the company's stock, valued at $1,796,552.52. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 0.90% of the stock is owned by insiders.

Wall Street Analyst Weigh In

AFL has been the subject of a number of recent research reports. Evercore ISI lifted their price objective on shares of Aflac from $84.00 to $90.00 and gave the company an "underperform" rating in a research note on Thursday, September 26th. Citigroup boosted their price objective on Aflac from $84.00 to $93.00 and gave the company a "neutral" rating in a research note on Tuesday, July 23rd. Piper Sandler increased their price objective on Aflac from $114.00 to $122.00 and gave the stock an "overweight" rating in a report on Wednesday, October 2nd. Truist Financial lifted their target price on Aflac from $82.00 to $100.00 and gave the company a "hold" rating in a report on Friday, August 2nd. Finally, Wells Fargo & Company increased their price target on shares of Aflac from $90.00 to $106.00 and gave the stock an "equal weight" rating in a report on Thursday, October 10th. Three research analysts have rated the stock with a sell rating, ten have issued a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average price target of $97.53.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.